XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes in Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of adoption of ASU No. 2016-13
Balance at January 1, 2023 adjusted for change in accounting principle
Total Amalgamated Financial Corp. Stockholders' Equity
Total Amalgamated Financial Corp. Stockholders' Equity
Cumulative effect of adoption of ASU No. 2016-13
Total Amalgamated Financial Corp. Stockholders' Equity
Balance at January 1, 2023 adjusted for change in accounting principle
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative effect of adoption of ASU No. 2016-13
Retained Earnings
Balance at January 1, 2023 adjusted for change in accounting principle
Accumulated Other Comprehensive Loss, net of income taxes
Treasury Stock, at cost
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022             30,700,198              
Beginning balance at Dec. 31, 2022 $ 508,955 $ (17,825) $ 491,130 $ 508,822 $ (17,825) $ 490,997 $ 307 $ 286,947 $ 330,275 $ (17,825) $ 312,450 $ (108,707) $ 0 $ 133
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 21,338     21,338         21,338          
Repurchase of common stock (in shares)             (128,803)              
Repurchase of common stock (2,425)     (2,425)                 (2,425)  
Common stock issued under Employee Stock Purchase Plan (in shares)             21,919              
Common stock issued under Employee Stock Purchase Plan 388     388       (25)         413  
Dividends on common stock, $0.10 per share (3,115)     (3,115)         (3,115)          
Exercise of stock options, net of repurchases (in shares)             6,631              
Exercise of stock options, net of repurchases (91)     (91)       (91)            
Restricted stock units vesting, net of repurchases (in shares)             42,354              
Restricted stock units vesting, net of repurchases (494)     (494)       (354)         (140)  
Stock-based compensation expense 1,037     1,037       1,037            
Other comprehensive income, net of taxes 11,390     11,390               11,390    
Ending balance (in shares) at Mar. 31, 2023             30,642,299              
Ending balance at Mar. 31, 2023 $ 519,158     519,025     $ 307 287,514 330,673     (97,317) (2,152) 133
Beginning balance (in shares) at Dec. 31, 2023 30,428,359           30,428,359              
Beginning balance at Dec. 31, 2023 $ 585,364     585,231     $ 307 288,232 388,033     (86,004) (5,337) 133
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income 27,249     27,249         27,249          
Repurchase of common stock (in shares)             (10,000)              
Repurchase of common stock (285)     (285)                 (285)  
Common stock issued under Employee Stock Purchase Plan (in shares)             10,175              
Common stock issued under Employee Stock Purchase Plan 244     244       60         184  
Dividends on common stock, $0.10 per share $ (3,092)     (3,092)         (3,092)          
Exercise of stock options, net of repurchases (in shares) 42,000           24,540              
Exercise of stock options, net of repurchases $ 0             (426)         426  
Restricted stock units vesting, net of repurchases (in shares)             57,319              
Restricted stock units vesting, net of repurchases (755)     (755)       (1,749)         994  
Stock-based compensation expense 1,081     1,081       1,081            
Other comprehensive income, net of taxes $ 7,132     7,132               7,132    
Ending balance (in shares) at Mar. 31, 2024 30,510,393           30,510,393              
Ending balance at Mar. 31, 2024 $ 616,938     $ 616,805     $ 307 $ 287,198 $ 412,190     $ (78,872) $ (4,018) $ 133